Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.1.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von E. Gjersdal und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gjersdal, E., Larsen, L., Ettrup, K., Vestergaard, P., Nielsen, E., Karmisholt, J., Muller, H., & Dal, J. (2025). Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.1.12
Vancouver
Gjersdal E, Larsen L, Ettrup K, Vestergaard P, Nielsen E, Karmisholt J, et al. Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.1.12
BibTeX
@article{Gjersdal2025,
author = {Gjersdal, E. and Larsen, L.B. and Ettrup, K.S. and Vestergaard, P. and Nielsen, E.H. and Karmisholt, J.S. and Muller, H.L. and Dal, J.},
title = {Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.1.12}
}
EUVIMED